Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment DOI Creative Commons
Fengrui Liu, Senlin Li,

Chengcheng Huang

и другие.

RSC Advances, Год журнала: 2025, Номер 15(15), С. 11675 - 11687

Опубликована: Янв. 1, 2025

We developed a glutathione (GSH) responsive nanoplatform for the co-delivery of sorafenib (Sor) and brusatol (Bru). This enhanced Bru’s efficacy increased Sor’s sensitivity. innovative approach effectiveness in hepatocellular carcinoma (HCC) treatment.

Язык: Английский

Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment DOI Creative Commons
Fengrui Liu, Senlin Li,

Chengcheng Huang

и другие.

RSC Advances, Год журнала: 2025, Номер 15(15), С. 11675 - 11687

Опубликована: Янв. 1, 2025

We developed a glutathione (GSH) responsive nanoplatform for the co-delivery of sorafenib (Sor) and brusatol (Bru). This enhanced Bru’s efficacy increased Sor’s sensitivity. innovative approach effectiveness in hepatocellular carcinoma (HCC) treatment.

Язык: Английский

Процитировано

0